Radioligand binding affinity and biological activity of the enantiomers of a chiral melatonin analogue

• Published in: European journal of pharmacology Vol. 287; no. 3; pp. 239 - 243
• Main Authors: Sugden, David, Davies, David J., Garratt, Peter J., Jones, Robert, Vonhoff, Stefan
• Format: Journal Article
• Language: English
• Published: Amsterdam Elsevier B.V 20.12.1995; Elsevier
• Subjects: Animals; Binding site; Binding, Competitive; Biological and medical sciences; Brain - metabolism; Carbazoles - administration & dosage; Carbazoles - pharmacology; Chickens; Chiral analog; Circadian Rhythm - drug effects; Hormones. Endocrine system; Iodine Radioisotopes; Lethal Dose 50; Medical sciences; Melanophore, Xenopus laevis; Melanophores - metabolism; Melatonin; Melatonin - analogs & derivatives; Melatonin - pharmacology; Pharmacology. Drug treatments; Pineal Gland - metabolism; Radioligand Assay; Stereoisomerism; Xenopus laevis; Melatonin; Chiral analog; Binding site; Melanophore, Xenopus laevis; Ligand binding; Analog; Carbazole derivatives; Enantiomer; Aminoacid derivative hormone; Melanophore; In vitro; Biological activity; Melatonine; Pineal hormone; Hormonal receptor
• ISSN: 0014-2999; 1879-0712
• DOI: 10.1016/0014-2999(95)00489-0

Melatonin, a hormone secreted by the pineal gland, can act on the central circadian oscillator in the suprachiasmatic nucleus of the hypothalamus. It has been proposed that melatonin or its analogues may be useful in restoring disturbed circadian rhythms in jet-lag, shift-work and some blind subjects, and as sleep-promoting agents. In the present study, the (−)- and (+)-enantiomers of N-acetyl-4-aminomethyl-6-methoxy-9-methyl-1,2,3,4-tetrahydrocarbazole (AMMTC) were separated and tested. The affinity of the enantiomers at the specific 2-[ 125I]iodomelatonin binding site in chick brain membranes was compared in competition assays, and their biological activity in a specific melatonin receptor bioassay, aggregation of pigment granules in Xenopus laevis melanophores. The (−)-enantiomer of AMMTC was 130-fold and 230-fold more potent than the (+)-enantiomer in competition radioligand binding assays and melanophores, respectively. Both enantiomers are melatonin receptor agonists; (−)-AMMTC is slightly more potent than melatonin itself. As the tetrahydrocarbazole nucleus holds the C-3 amido side-chain of AMMTC in a restricted conformation, the analogues will be useful in modelling the melatonin receptor binding site.